E2 - Endovascular Engineering Logo - medical devices

E2 - Endovascular Engineering

medical devices
China's Best One-Stop Medical Equipment Provider
About

Endovascular Engineering, Inc. (E2) is a medical device company based in Menlo Park, California. The company is dedicated to developing advanced technologies for clot removal, specifically targeting venous thromboembolism (VTE) and pulmonary embolism (PE). E2 is led by an experienced executive team and collaborates with clinical partners in interventional cardiology and radiology to enhance treatment outcomes for patients with blood clots. E2's flagship product is the Hēlo™ Thrombectomy System, a mechanical device designed to safely and effectively remove blood clots from the lungs and veins. The Hēlo™ system is currently undergoing clinical evaluation through the ENGULF Investigational Device Exemption (IDE) study at multiple leading U.S. medical centers. E2 primarily serves healthcare providers in interventional cardiology, interventional radiology, and vascular surgery, focusing on hospitals and medical centers that perform endovascular procedures. The company is committed to innovation and collaboration to improve the treatment landscape for VTE.

Technologies
Outlook Blue Host Microsoft Office 365 GoDaddy Hosting Apache Mobile Friendly WordPress.org Google Tag Manager Remote
Keywords
medical equipment manufacturing next-generation clot removal pulmonary embolism treatment minimally invasive thrombectomy clinical science in thrombectomy large bore performance medical device research catheter expansion technology agitation mechanism large bore clot engagement clinical trial results venture-backed medical device interventional radiology clinical trial safety data clinical research device safety profile venture capital funding medical device innovation small profile catheter clinical device innovation venture capital fda 510(k) process minimally invasive pe treatment patient care clot removal clinical feasibility trial fda-approved study venous thromboembolism clinical efficacy minimally invasive
Company Information
  • Employees 37
  • Founded 2019
  • Annual Revenue $4500000
  • Total Funding $57000000
Location

3925 Bohannon Dr, Menlo Park, California, United States, 94025-1002

Related Companies
Companies in the same industry